Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics

Xiaoxv DongSchool of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 PR ChinaJing FuSchool of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 PR ChinaXingbin YinSchool of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 PR ChinaSali CaoSchool of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 PR ChinaXuechun LiSchool of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 PR ChinaLongfei LinSchool of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 PR ChinaJian NiAffiliated Hospital, Inner Mongolia University for Nationalities, Tongliao, 028000 PR ChinaJian NiSchool of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 PR China
2016en
ABI

Аннотация

Emodin is a natural anthraquinone derivative that occurs in many widely used Chinese medicinal herbs, such as Rheum palmatum, Polygonum cuspidatum and Polygonum multiflorum. Emodin has been used as a traditional Chinese medicine for over 2000 years and is still present in various herbal preparations. Emerging evidence indicates that emodin possesses a wide spectrum of pharmacological properties, including anticancer, hepatoprotective, antiinflammatory, antioxidant and antimicrobial activities. However, emodin could also lead to hepatotoxicity, kidney toxicity and reproductive toxicity, particularly in high doses and with long-term use. Pharmacokinetic studies have demonstrated that emodin has poor oral bioavailability in rats because of its extensive glucuronidation. This review aims to comprehensively summarize the pharmacology, toxicity and pharmacokinetics of emodin reported to date with an emphasis on its biological properties and mechanisms of action. Copyright © 2016 John Wiley & Sons, Ltd.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0